RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients

BACKGROUND: A major obstacle in treating colorectal cancer (CRC) is the acquired resistance to chemotherapeutic agents. An important protein in the regulation of cancer cell death and clinical outcome is Raf kinase inhibitor protein (RKIP). In contrast, activated signal transducer and activator of t...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Cross-Knorr, Sam, Lu, Shaolei, Perez, Kimberly, Guevara, Sara, Brilliant, Kate, Pisano, Claudio, Quesenberry, Peter J, Resnick, Murray B, Chatterjee, Devasis
Format: Artigo
Język:Inglês
Wydane: BioMed Central 2013
Hasła przedmiotowe:
Research Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3856511/
https://ncbi.nlm.nih.gov/pubmed/24098947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-463
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy